Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDVRG.L Regulatory News (DVRG)

  • There is currently no data for DVRG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update; exclusivity agreement with Microsaic

20 Dec 2023 12:30

RNS Number : 4962X
Deepverge PLC
20 December 2023
 

20 December 2023

 

DeepVerge plc

 

("DeepVerge" or "the Company")

 

Update; exclusivity agreement with Microsaic

 

Further to the previous notification on 13 December 2023, the Company has today entered into an agreement with Microsaic Systems plc ("Microsaic") granting Microsaic a period of exclusivity ("Exclusivity Period") in respect of the potential sale of certain assets currently held within subsidiaries relating to its Modern Water business ("the 'Business").

The assets broadly comprise equipment for the laboratory-based manufacturing of bio-reagents used in related water testing equipment currently based at the Company's York laboratory and include all IP and rights to the related water testing equipment including LX, FX and Continuous Toxic Measuring ("CTM") machines and water membrane technology.

The Business specifically excludes the voltammetry technology and equipment manufactured by B3 Electronic Design Pty Ltd in Perth, Australia.

The granting of the Exclusivity Period follows the receipt of an indicative outline proposal from Microsaic to purchase the Business for £100,000 in cash payable on completion ('the Proposal').

 

In addition upon completion Microsaic Systems is willing to discharge all intra company debt (sum to be verified) between DeepVerge and Microsaic as part of the consideration for the acquisition.

 

The Exclusivity Period runs until the earlier of (a) 16 January 2024, (b) the signature of a legally binding sale & purchase agreement between the DeepVerge and Microsaic for the Business ("the Transaction") and (c) withdrawal of the Proposal by Microsaic.

No consideration has been received by DeepVerge for the granting of the Exclusivity Period.

During the Exclusivity Period DeepVerge shall not solicit, advertise, market or enter any other negotiations, arrangements or options with any third parties relating to the sale of the Business and shall not complete the Transaction other than with Microsaic.

The Exclusivity Period may, at its sole discretion, be extended by Deepverge for a further period for the Transaction to be finalised.

The Exclusivity Period is designed to provide Microsaic with time to conclude its due diligence, obtain binding commitments for a fundraising, including working capital for the enlarged Microsaic business, and consideration for the Transaction, and to negotiate and sign a detailed sale and purchase agreement. There is no guarantee that the Transaction will occur, or that the outline terms indicated in the Proposal will be those on which a binding agreement is signed. As previously notified on 13 December 2023, any proceeds from a disposal transaction is likely to realise insufficient value to avoid the closure or administration of the relevant Group subsidiaries.

DeepVerge director Dr Nigel Burton is also a director of Microsaic. Given his conflict of interest, Dr Burton is not involved in the DeepVerge board's consideration of the Transaction. Ross Andrews is the only independent director ("Independent Director").

As previously notified, the cancellation of the admission of the Company's shares to trading on AIM ("Cancellation") is expected therefore to take place with effect from 7.00 a.m. on 27 December 2023.

If the Transaction occurs before the date of Cancellation it would constitute a related party transaction under the AIM Rules for Companies (the "AIM Rules") and would require treatment in accordance with AIM Rule 13 (related party transactions) and AIM Rule 15.

The Company will no longer be subject to the AIM Rules once Cancellation has occurred. In the event that Cancellation occurs before a binding agreement is entered into for the sale of the Business to Microsaic, the requirements of AIM Rule 13 and 15 would cease to apply to the transaction.

The Independent Director expects that if the Transaction occurs, it is likely to occur at a point following Cancellation.

Further updates will be given as appropriate.

DeepVerge plc

Nigel Burton, Interim CEO

+44 (0) 7785 234447

SPARK Advisory Partners Limited

(Nominated Adviser)

Neil Baldwin

+44 (0) 113 370 8974

Turner Pope Investments (TPI) Limited (Broker)

Andy Thacker/James Pope

+44 (0) 20 3657 0050

 

This announcement contains inside information as stipulated under the UK version of the Market Abuse Regulation No 596/2014 which is part of English Law by virtue of the European (Withdrawal) Act 2018, as amended. On publication of this announcement via a Regulatory Information Service, this information is considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCMZMZZZGRGFZM
Date   Source Headline
30th Sep 20224:35 pmRNSPrice Monitoring Extension
30th Sep 202211:06 amRNSSecond Price Monitoring Extn
30th Sep 202211:00 amRNSPrice Monitoring Extension
22nd Sep 20227:00 amRNSInterim Results
13th Sep 20227:00 amRNSBlue Carbon Resilience project
5th Aug 20227:00 amRNSTrading Update
1st Aug 20227:00 amRNSModern Water secures £2.1m projects
20th Jul 20221:42 pmRNSResult of AGM
20th Jul 20227:00 amRNSDeepVerge to explore options for Labskin Division
19th Jul 20224:41 pmRNSSecond Price Monitoring Extn
19th Jul 20224:36 pmRNSPrice Monitoring Extension
18th Jul 20227:01 amRNSModern Water monitoring systems deal worth £1.4m
4th Jul 20227:00 amRNSSkin Trust Club - update
30th Jun 20227:00 amRNSModern Water Q2 orders exceed £3m, RPT
27th Jun 202211:50 amRNSNotice of AGM
23rd Jun 20227:12 amRNSFinal Results
13th Jun 20227:00 amRNSNotice of Final Results and Annual Report
1st Jun 20221:36 pmRNSSkin Trust Club wins Best New Disrupter Brand
30th May 20227:00 amRNSTesting Services Framework Ag with Abingdon Health
26th Apr 20227:00 amRNSDeepVerge presents at Global Group Investor Summit
19th Apr 20227:00 amRNSUpdate; Manuf'g Service Agreement with Microsaic
19th Apr 20227:00 amRNSHolding(s) in Company
29th Mar 20227:00 amRNSMoU with Abingdon Health for lateral flow tests
28th Mar 20227:00 amRNS1st UK Deployments of Microtox®PD in Wastewater
18th Mar 202211:05 amRNSSecond Price Monitoring Extn
18th Mar 202211:00 amRNSPrice Monitoring Extension
17th Mar 202210:59 amRNSDirector Dealing
17th Mar 20227:00 amRNSAcquisition; Loan Facility for global expansion
11th Mar 20229:05 amRNSSecond Price Monitoring Extn
11th Mar 20229:00 amRNSPrice Monitoring Extension
11th Mar 20227:00 amRNSDeepVerge Q1 production orders up 39% to £5m
21st Feb 20227:00 amRNS82% of Skin Trust Club members purchase via App
19th Jan 20227:00 amRNSMicrotoxPD detects 3 COVID variants of concern
17th Jan 202211:05 amRNSSecond Price Monitoring Extn
17th Jan 202211:00 amRNSPrice Monitoring Extension
11th Jan 20227:00 amRNSTrading Update
6th Jan 20227:00 amRNSMicrotox CTM installed ahead of Winter Olympics
13th Dec 20217:00 amRNSAmends to Agreement with Microsaic Systems; RPT
10th Dec 20219:00 amRNSPrice Monitoring Extension
10th Dec 20217:00 amRNSCompact Microtox® PD launch scheduled for Q1 2022
9th Dec 20214:41 pmRNSSecond Price Monitoring Extn
9th Dec 20214:36 pmRNSPrice Monitoring Extension
26th Nov 20217:00 amRNSRelated Party Transaction
11th Nov 20217:00 amRNSU.S. launch of Skin Trust Club at Beauty Connect
4th Nov 20218:00 amRNSPDMR Dealing
4th Nov 20217:00 amRNSGrant supports DeepVerge Centre of Excellence
3rd Nov 20217:00 amRNSConfirmation of Post-Offer Intention Statements
28th Oct 20217:00 amRNSMicrotox® PD installations as part of nat'l trial
21st Oct 20219:05 amRNSSecond Price Monitoring Extn
21st Oct 20219:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.